A detailed history of Arcataur Capital Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Arcataur Capital Management LLC holds 1,654 shares of VRTX stock, worth $782,011. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,654
Previous 1,654 -0.0%
Holding current value
$782,011
Previous $775 Million 0.78%
% of portfolio
0.26%
Previous 0.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$392.81 - $485.53 $2,356 - $2,913
-6 Reduced 0.36%
1,654 $775 Million
Q1 2024

Apr 26, 2024

SELL
$407.69 - $446.08 $250,729 - $274,339
-615 Reduced 27.03%
1,660 $694 Million
Q4 2023

Feb 07, 2024

SELL
$343.0 - $410.68 $4,459 - $5,338
-13 Reduced 0.57%
2,275 $926 Million
Q2 2023

Jul 26, 2023

BUY
$314.42 - $351.91 $719,392 - $805,170
2,288 New
2,288 $805 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Arcataur Capital Management LLC Portfolio

Follow Arcataur Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcataur Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arcataur Capital Management LLC with notifications on news.